X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (104) 104
humans (97) 97
brain neoplasms - genetics (80) 80
clinical neurology (71) 71
gliomas (71) 71
oncology (66) 66
tumors (65) 65
male (57) 57
oligodendroglioma (56) 56
female (55) 55
glioma (55) 55
adult (52) 52
1p/19q (50) 50
1p/19q co-deletion (49) 49
middle aged (48) 48
mutation (47) 47
prognosis (46) 46
brain neoplasms - pathology (45) 45
medicine & public health (45) 45
survival (43) 43
classification (42) 42
oligodendroglioma - genetics (41) 41
isocitrate dehydrogenase - genetics (39) 39
chromosomes, human, pair 1 - genetics (38) 38
pathology (38) 38
glioblastoma (37) 37
chromosome deletion (36) 36
chemotherapy (35) 35
19q (32) 32
aged (32) 32
cancer (32) 32
glioma - genetics (32) 32
chromosomes, human, pair 19 - genetics (31) 31
analysis (29) 29
neurosciences (29) 29
brain cancer (28) 28
neurology (28) 28
brain neoplasms - diagnosis (27) 27
brain tumors (26) 26
temozolomide (26) 26
phase-iii trial (24) 24
oligodendroglioma - pathology (23) 23
young adult (22) 22
anaplastic oligodendroglioma (21) 21
diagnosis (21) 21
idh (21) 21
retrospective studies (21) 21
surgery (21) 21
astrocytoma (20) 20
idh1 (20) 20
genetic aspects (19) 19
radiotherapy (19) 19
19q co-deletion (18) 18
1p/19q loss (18) 18
atrx (18) 18
brain neoplasms - therapy (18) 18
central-nervous-system (18) 18
gene deletion (18) 18
glioma - pathology (18) 18
idh2 mutations (18) 18
idh mutation (16) 16
mgmt (16) 16
mutations (16) 16
neoplasm grading (16) 16
oligodendroglioma - diagnosis (16) 16
tumor proteins (16) 16
adolescent (15) 15
biomarkers, tumor - genetics (15) 15
glioma - diagnosis (15) 15
immunohistochemistry (15) 15
isocitrate dehydrogenase (15) 15
low-grade gliomas (15) 15
mutation - genetics (15) 15
astrocytomas (14) 14
brain neoplasms - classification (14) 14
chromosomes, human, pair 1 (14) 14
european organization (14) 14
magnetic resonance imaging (14) 14
neurosurgery (14) 14
1p/19q codeletion (13) 13
adjuvant procarbazine (13) 13
brain neoplasms - metabolism (13) 13
chromosomes, human, pair 19 (13) 13
clonal deletion (13) 13
glioma - classification (13) 13
patients (13) 13
1p/19q deletion (12) 12
brain neoplasms - mortality (12) 12
deletion (12) 12
gene expression (12) 12
glioblastoma - genetics (12) 12
glioblastoma-multiforme (12) 12
methylation (12) 12
mgmt promoter methylation (12) 12
radiation-therapy (12) 12
radiology, nuclear medicine & medical imaging (12) 12
chromosomes (11) 11
dna methylation (11) 11
medical colleges (11) 11
molecular classification (11) 11
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal Article
Journal Article
ANNALS OF NUCLEAR MEDICINE, ISSN 0914-7187, 04/2019, Volume 33, Issue 4, pp. 295 - 302
Objective The role of amino acid positron emission tomography (PET) in glioma grading and outcome prognostication has not yet been well established. This is... 
Amino acid PET | Glioma | 1p/19q co-deletion | WHO 2016 | AMINO-ACID PET | IDH mutation | CLASSIFICATION | DOPA | PROGNOSTIC VALUE | TUMORS | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING | PREDICTION
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 11/2018, Volume 140, Issue 2, pp. 297 - 306
Journal Article
World Journal of Surgical Oncology, ISSN 1477-7819, 06/2018, Volume 16, Issue 1, pp. 110 - 6
Background: The response to temozolomide (TMZ) treatment in small-cell lung cancer (SCLC) correlated with O(6)-methylguanine-DNA methyltransferase (MGMT)... 
Pulmonary carcinoid | MGMT methylation | Large-cell neuroendocrine carcinoma | 1p/19q co-deletion | SURGERY | MANAGEMENT | RARE | CLASSIFICATION | COMBINATION | TUMORS | CHEMOTHERAPY | TEMOZOLOMIDE | LUNG-CANCER | ONCOLOGY | DNA METHYLTRANSFERASE | EXPERIENCE | Carcinoid Tumor - surgery | Prognosis | Humans | Middle Aged | DNA Repair Enzymes - genetics | Male | Promoter Regions, Genetic - genetics | Chromosomes, Human, Pair 19 - genetics | China | Tumor Suppressor Proteins - genetics | Adult | Female | Carcinoma, Large Cell - genetics | Retrospective Studies | Chromosomes, Human, Pair 1 - genetics | Chromosome Deletion | Lung Neoplasms - genetics | Carcinoma, Neuroendocrine - genetics | Carcinoma, Neuroendocrine - surgery | DNA Methylation - genetics | Disease-Free Survival | DNA Modification Methylases - genetics | Carcinoid Tumor - genetics | Carcinoma, Large Cell - surgery | Lung Neoplasms - surgery | Aged | Cancer patients | Methylation | Health aspects | Analysis | Brain cancer | Lung cancer | Fluorescence | Vertebra | Metastasis | Gene deletion | Cancer therapies | Metastases | O6-methylguanine-DNA methyltransferase | Clonal deletion | Surgery | Fluorescence in situ hybridization | DNA methylation | Deletion | Age | Deoxyribonucleic acid--DNA | Small cell lung carcinoma | Methylguanine | Radiation therapy | Patients | Oligodendroglioma | Chemotherapy | Hospitals | Medical prognosis | Biomarkers | DNA methyltransferase | Fatalities | Mutation | Temozolomide | Tumors
Journal Article
Journal of Neuro-Oncology, ISSN 0167-594X, 2/2018, Volume 136, Issue 3, pp. 523 - 531
Journal Article
ACTA NEUROPATHOLOGICA COMMUNICATIONS, ISSN 2051-5960, 06/2018, Volume 6, Issue 1, pp. 49 - 15
Journal Article
Cancer Management and Research, ISSN 1179-1322, 2019, Volume 11, pp. 4971 - 4984
The chr1p/19q co-deletion is a favorable prognostic factor in patients with lower grade glioma. The aim of this study was to reveal key genes for prognosis and... 
Prognostic signature | Lower grade glioma | 1p/19q co-deletion | Rbsurv | rbsurv | prognostic signature
Journal Article
Brain Tumor Pathology, ISSN 1433-7398, 7/2012, Volume 29, Issue 3, pp. 148 - 153
Journal Article
Interdisciplinary Neurosurgery, ISSN 2214-7519, 2016, Volume 5, Issue C, pp. 58 - 63
Abstract Background The impact of chromosomal 1p/19q co-deletion on the prognosis of oligodendrogliomas has been measured in many studies previously. However... 
Medical Education | Neurosurgery | Overall survival | Chromosomal 1p/19q co-deletion | Hazard ratio | Standardized mean difference | Progression free survival | Oligodendroglioma
Journal Article
British Journal of Neurosurgery, ISSN 0268-8697, 09/2019, Volume 33, Issue 5, pp. 536 - 540
Purpose: The 2016 WHO tumour classification highlights the role of IDH1/2 gene mutation and 1p/19q co-deletion in classifying grade II/III gliomas. A recent... 
grade II/III glioma | 1p/19q co-deletion | ATRX
Journal Article
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, ISSN 1619-7070, 03/2018, Volume 45, Issue 3, pp. 443 - 451
Purpose The molecular features isocitrate dehydrogenase (IDH) mutation and 1p/19q co-deletion have gained major importance for both glioma typing and prognosis... 
SURVIVAL | MRI | RESPONSE ASSESSMENT | IDH mutation | CLASSIFICATION | PROGNOSTIC VALUE | TUMORS | PROCARBAZINE | O-(2-F-18-FLUOROETHYL)-L-TYROSINE PET | GRADE II | Glioma | 1p/19q co-deletion | FET pet | VINCRISTINE | RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Journal Article
Acta Neuropathologica, ISSN 0001-6322, 5/2015, Volume 129, Issue 5, pp. 679 - 693
Journal Article